441 related articles for article (PubMed ID: 21107520)
1. Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failure.
Kluth O; Mirhashemi F; Scherneck S; Kaiser D; Kluge R; Neschen S; Joost HG; Schürmann A
Diabetologia; 2011 Mar; 54(3):605-16. PubMed ID: 21107520
[TBL] [Abstract][Full Text] [Related]
2. Forkhead box O1/pancreatic and duodenal homeobox 1 intracellular translocation is regulated by c-Jun N-terminal kinase and involved in prostaglandin E2-induced pancreatic beta-cell dysfunction.
Meng Z; Lv J; Luo Y; Lin Y; Zhu Y; Nie J; Yang T; Sun Y; Han X
Endocrinology; 2009 Dec; 150(12):5284-93. PubMed ID: 19837872
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(1-7) Improves Islet β-cell Dedifferentiation by Activating PI3K/Akt/FoxO1 Pathway.
Guo H; Guo D; An M; Zhang R; Wang C; He J
Protein Pept Lett; 2023; 30(12):1009-1019. PubMed ID: 37953618
[TBL] [Abstract][Full Text] [Related]
4. Activation of SIRT1 protects pancreatic β-cells against palmitate-induced dysfunction.
Wu L; Zhou L; Lu Y; Zhang J; Jian F; Liu Y; Li F; Li W; Wang X; Li G
Biochim Biophys Acta; 2012 Nov; 1822(11):1815-25. PubMed ID: 22968147
[TBL] [Abstract][Full Text] [Related]
5. Protective action of liraglutide in beta cells under lipotoxic stress via PI3K/Akt/FoxO1 pathway.
Shao S; Nie M; Chen C; Chen X; Zhang M; Yuan G; Yu X; Yang Y
J Cell Biochem; 2014 Jun; 115(6):1166-75. PubMed ID: 24415347
[TBL] [Abstract][Full Text] [Related]
6. FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice.
Zhang T; Kim DH; Xiao X; Lee S; Gong Z; Muzumdar R; Calabuig-Navarro V; Yamauchi J; Harashima H; Wang R; Bottino R; Alvarez-Perez JC; Garcia-Ocaña A; Gittes G; Dong HH
Endocrinology; 2016 Mar; 157(3):1055-70. PubMed ID: 26727107
[TBL] [Abstract][Full Text] [Related]
7. Nucleo-cytosolic shuttling of FoxO1 directly regulates mouse Ins2 but not Ins1 gene expression in pancreatic beta cells (MIN6).
Meur G; Qian Q; da Silva Xavier G; Pullen TJ; Tsuboi T; McKinnon C; Fletcher L; Tavaré JM; Hughes S; Johnson P; Rutter GA
J Biol Chem; 2011 Apr; 286(15):13647-56. PubMed ID: 21335550
[TBL] [Abstract][Full Text] [Related]
8. Regulation of forkhead box O1 (FOXO1) by protein kinase B and glucocorticoids: different mechanisms of induction of beta cell death in vitro.
Kaiser G; Gerst F; Michael D; Berchtold S; Friedrich B; Strutz-Seebohm N; Lang F; Häring HU; Ullrich S
Diabetologia; 2013 Jul; 56(7):1587-95. PubMed ID: 23435785
[TBL] [Abstract][Full Text] [Related]
9. Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes.
Habibe JJ; Clemente-Olivo MP; Scheithauer TPM; Rampanelli E; Herrema H; Vos M; Mieremet A; Nieuwdorp M; van Raalte DH; Eringa EC; de Vries CJM
Diabetologia; 2022 Oct; 65(10):1721-1733. PubMed ID: 35802167
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 expression in rodent models.
Chen F; Sha M; Wang Y; Wu T; Shan W; Liu J; Zhou W; Zhu Y; Sun Y; Shi Y; Bleich D; Han X
Diabetologia; 2016 Feb; 59(2):316-24. PubMed ID: 26564177
[TBL] [Abstract][Full Text] [Related]
11. Squamosamide Derivative FLZ Protects Pancreatic β-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway.
Kong X; Zhang L; Hua X; Ma X
J Diabetes Res; 2015; 2015():803986. PubMed ID: 26167511
[TBL] [Abstract][Full Text] [Related]
12. Dracorhodin perchlorate protects pancreatic β-cells against glucotoxicity- or lipotoxicity-induced dysfunction and apoptosis in vitro and in vivo.
Liu L; Liang C; Mei P; Zhu H; Hou M; Yu C; Song Z; Bao Y; Huang Y; Yi J; Wang S; Wu Y; Zheng L; Sun Y; Wang G; Huo M; Yang S; Sun L; Li Y
FEBS J; 2019 Sep; 286(18):3718-3736. PubMed ID: 31349381
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of kinase-negative protein kinase Cdelta in pancreatic beta-cells protects mice from diet-induced glucose intolerance and beta-cell dysfunction.
Hennige AM; Ranta F; Heinzelmann I; Düfer M; Michael D; Braumüller H; Lutz SZ; Lammers R; Drews G; Bosch F; Häring HU; Ullrich S
Diabetes; 2010 Jan; 59(1):119-27. PubMed ID: 19826167
[TBL] [Abstract][Full Text] [Related]
14. Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas.
Al-Masri M; Krishnamurthy M; Li J; Fellows GF; Dong HH; Goodyer CG; Wang R
Diabetologia; 2010 Apr; 53(4):699-711. PubMed ID: 20033803
[TBL] [Abstract][Full Text] [Related]
15. Endogenous advanced glycation end products in pancreatic islets after short-term carbohydrate intervention in obese, diabetes-prone mice.
Kehm R; Rückriemen J; Weber D; Deubel S; Grune T; Höhn A
Nutr Diabetes; 2019 Mar; 9(1):9. PubMed ID: 30858378
[TBL] [Abstract][Full Text] [Related]
16. Curcumin attenuates palmitate-induced apoptosis in MIN6 pancreatic β-cells through PI3K/Akt/FoxO1 and mitochondrial survival pathways.
Hao F; Kang J; Cao Y; Fan S; Yang H; An Y; Pan Y; Tie L; Li X
Apoptosis; 2015 Nov; 20(11):1420-32. PubMed ID: 26330141
[TBL] [Abstract][Full Text] [Related]
17. Development of diabetes in obese, insulin-resistant mice: essential role of dietary carbohydrate in beta cell destruction.
Jürgens HS; Neschen S; Ortmann S; Scherneck S; Schmolz K; Schüler G; Schmidt S; Blüher M; Klaus S; Perez-Tilve D; Tschöp MH; Schürmann A; Joost HG
Diabetologia; 2007 Jul; 50(7):1481-9. PubMed ID: 17437079
[TBL] [Abstract][Full Text] [Related]
18. FoxO1 inhibition promotes differentiation of human embryonic stem cells into insulin producing cells.
Yu F; Wei R; Yang J; Liu J; Yang K; Wang H; Mu Y; Hong T
Exp Cell Res; 2018 Jan; 362(1):227-234. PubMed ID: 29157981
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of iPSCs into insulin-producing cells via adenoviral transfection of PDX-1, NeuroD1 and MafA.
Wang L; Huang Y; Guo Q; Fan X; Lu Y; Zhu S; Wang Y; Bo X; Chang X; Zhu M; Wang Z
Diabetes Res Clin Pract; 2014 Jun; 104(3):383-92. PubMed ID: 24794627
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-223 is essential for maintaining functional β-cell mass during diabetes through inhibiting both FOXO1 and SOX6 pathways.
Li Y; Deng S; Peng J; Wang X; Essandoh K; Mu X; Peng T; Meng ZX; Fan GC
J Biol Chem; 2019 Jul; 294(27):10438-10448. PubMed ID: 31118273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
